LADENBURG THALMANN FINANCIAL SERVICES INC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 35 filers reported holding ONCOCYTE CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2019$1,000
-80.0%
500
-80.0%
0.00%
Q3 2019$5,000
-73.7%
2,500
-66.7%
0.00%
Q2 2019$19,000
+850.0%
7,500
+1400.0%
0.00%
Q1 2019$2,000
+100.0%
5000.0%0.00%
Q4 2018$1,0000.0%5000.0%0.00%
Q3 2018$1,0000.0%5000.0%0.00%
Q2 2018$1,0000.0%5000.0%0.00%
Q1 2018$1,000
-50.0%
5000.0%0.00%
Q4 2017$2,000500
+2281.0%
0.00%
Q3 2016$0210.0%0.00%
Q2 2016$0210.0%0.00%
Q1 2016$0210.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,056,680$15,895,0002.92%
IHT Wealth Management, LLC 200$386,0000.19%
Family Management Corp 22,570$117,0000.08%
Artal Group S.A. 150,000$780,0000.01%
Destination Wealth Management 29,656$154,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$754,0000.01%
Advisor Group, Inc. 102$1,0000.00%
FIFTH THIRD BANCORP 210$1,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,233$12,0000.00%
View complete list of ONCOCYTE CORP shareholders